As Cvs Health (CVS) Shares Declined, Cls Investments Has Trimmed Stake by $1.13 Million; Green Valley Investors Lifted Exact Sciences (EXAS) Stake

February 19, 2018 - By Michael Collier

Cls Investments Llc decreased its stake in Cvs Health Corp (CVS) by 99.56% based on its latest 2017Q3 regulatory filing with the SEC. Cls Investments Llc sold 13,655 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 60 shares of the medical and nursing services company at the end of 2017Q3, valued at $5,000, down from 13,715 at the end of the previous reported quarter. Cls Investments Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $72.84 billion market cap company. The stock increased 2.00% or $1.41 during the last trading session, reaching $71.9. About 6.47M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 19, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Green Valley Investors Llc increased its stake in Exact Sciences Corp (EXAS) by 63.43% based on its latest 2017Q3 regulatory filing with the SEC. Green Valley Investors Llc bought 374,666 shares as the company’s stock rose 53.09% with the market. The institutional investor held 965,350 shares of the commercial physical & biological resarch company at the end of 2017Q3, valued at $45.49 million, up from 590,684 at the end of the previous reported quarter. Green Valley Investors Llc who had been investing in Exact Sciences Corp for a number of months, seems to be bullish on the $5.85B market cap company. The stock decreased 0.57% or $0.28 during the last trading session, reaching $48.86. About 1.23M shares traded. Exact Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since February 19, 2017 and is uptrending. It has outperformed by 441.54% the S&P500.




Since September 1, 2017, it had 0 buys, and 8 sales for $27.11 million activity. The insider COWARD D SCOTT sold 1,665 shares worth $87,474. LIDGARD GRAHAM PETER also sold $3.82M worth of Exact Sciences Corporation (NASDAQ:EXAS) shares.

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.26, from 1.27 in 2017Q2. It is negative, as 39 investors sold EXAS shares while 81 reduced holdings. 44 funds opened positions while 77 raised stakes. 93.65 million shares or 1.18% less from 94.77 million shares in 2017Q2 were reported. Asset Mgmt Inc owns 4,340 shares for 0.01% of their portfolio. Gofen Glossberg Limited Co Il invested in 0.02% or 9,200 shares. Salem Counselors Incorporated accumulated 1,000 shares. First Mercantile Trust reported 38,472 shares. Brown Brothers Harriman & holds 0% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS) for 250 shares. Advisory Svcs Ntwk Limited Company holds 0% or 50 shares. Axa holds 58,400 shares or 0.01% of its portfolio. Meeder Asset reported 0.01% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS). Canada Pension Plan Inv Board owns 0.09% invested in Exact Sciences Corporation (NASDAQ:EXAS) for 930,000 shares. Voya Investment Management Limited Liability Corporation has invested 0.22% in Exact Sciences Corporation (NASDAQ:EXAS). Tiverton Asset Management Llc holds 0.66% or 247,500 shares. Parallax Volatility Advisers LP stated it has 17,804 shares. Putnam Invests Limited Company reported 0% in Exact Sciences Corporation (NASDAQ:EXAS). State Common Retirement Fund invested in 211,819 shares or 0.01% of the stock. Nuveen Asset stated it has 0% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS).

Green Valley Investors Llc, which manages about $2.05B US Long portfolio, decreased its stake in Air Products & Chemicals Inc (NYSE:APD) by 8,824 shares to 292,769 shares, valued at $44.27M in 2017Q3, according to the filing. It also reduced its holding in Tjx Cos Inc (NYSE:TJX) by 17,370 shares in the quarter, leaving it with 616,921 shares, and cut its stake in Johnson & Johnson (NYSE:JNJ).

Among 18 analysts covering EXACT Sciences (NASDAQ:EXAS), 10 have Buy rating, 1 Sell and 7 Hold. Therefore 56% are positive. EXACT Sciences had 65 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, July 20. On Friday, February 26 the stock rating was maintained by Empire with “Sell”. The rating was maintained by Canaccord Genuity on Tuesday, October 3 with “Buy”. The rating was maintained by Cowen & Co with “Buy” on Wednesday, December 20. The firm earned “Outperform” rating on Tuesday, October 31 by Robert W. Baird. Canaccord Genuity maintained Exact Sciences Corporation (NASDAQ:EXAS) rating on Wednesday, May 31. Canaccord Genuity has “Buy” rating and $4000 target. On Thursday, February 25 the stock rating was downgraded by Roth Capital to “Neutral”. The stock has “Hold” rating by Lake Street on Tuesday, November 1. Jefferies maintained the stock with “Buy” rating in Thursday, February 25 report. The firm earned “Buy” rating on Friday, October 20 by Jefferies.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It worsened, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Atria Invs Ltd Liability Co, a North Carolina-based fund reported 38,883 shares. Moreover, Wg Shaheen Associates Dba Whitney has 0.84% invested in CVS Health Corporation (NYSE:CVS). Fishman Jay A Ltd Mi owns 20,884 shares. Bridges Inv Inc has 0.04% invested in CVS Health Corporation (NYSE:CVS). Williams Jones Lc reported 61,400 shares stake. Smith Salley Associate invested in 0.89% or 57,008 shares. Natixis Asset Management accumulated 10,745 shares. Signaturefd Limited Liability holds 9,168 shares or 0.1% of its portfolio. Cim Inv Mangement invested 0.44% of its portfolio in CVS Health Corporation (NYSE:CVS). Covenant Multifamily Offices Lc owns 38,965 shares. Columbia Asset Mngmt holds 9,026 shares. Alpine Woods Ltd Liability Company accumulated 221,606 shares or 0.92% of the stock. Seabridge Inv Advsr Lc invested in 95 shares. Griffin Asset invested in 8,199 shares. Cardinal Cap Mngmt stated it has 1.31% of its portfolio in CVS Health Corporation (NYSE:CVS).

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 72 analyst reports since July 22, 2015 according to SRatingsIntel. Needham upgraded CVS Health Corporation (NYSE:CVS) on Friday, November 10 to “Buy” rating. The rating was maintained by Deutsche Bank on Thursday, August 20 with “Hold”. Oppenheimer maintained it with “Outperform” rating and $119.0 target in Friday, August 28 report. The rating was maintained by Robert W. Baird with “Hold” on Wednesday, January 17. The stock has “Hold” rating by Jefferies on Monday, December 12. As per Tuesday, December 26, the company rating was maintained by Tigress Financial. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Wednesday, October 18 by Jefferies. Deutsche Bank maintained CVS Health Corporation (NYSE:CVS) rating on Wednesday, July 22. Deutsche Bank has “Hold” rating and $117 target. The company was maintained on Friday, October 27 by Robert W. Baird. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Monday, September 25 by Robert W. Baird.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.